Applied Microarrays' '09 Sales Up 50 Percent on Demand for Custom Projects

According to the firm's CEO, the majority of the company's sales come from contract manufacturing, while sales of legacy CodeLink bioarray products now account for less than a tenth of AMI's total revenues.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.